drugset
Drugs / CD.JEVAX™
last change Feb 2022 re-read 2 minutes ago

CD.JEVAX™

also known as Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine · Live attenuated SA 14-14-2 Japanese Encephalitis vaccine · SA14 14 2 vaccine
Developed for
Japanese encephalitis
Investigated by
PATH · DFNet Research Inc. · International Centre for Diarrhoeal Disease Research, Bangladesh · Research Institute for Tropical Medicine · Syneos Health

Trials 2 · a red edge is where a trial was stopped

today NCT02880865 · Ph 4 NCT02514746 · Ph 4
20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02880865 Oct 2016 → May 2017 Japanese encephalitis, measles, mumps infectious disease, rubella PATH Completed No outcome recorded
Phase 4 NCT02514746 Jul 2015 → Dec 2016 Japanese encephalitis PATH Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01396512 Comparator Jul 2011 → Mar 2013 Japanese encephalitis Sanofi Pasteur, a Sanofi Company Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as CD.JEVAX “Participants will receive a single dose of the Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine), CD.JEVAX™ on Day 0” NCT01396512 ↗
Known as Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02514746 ↗
Known as Live attenuated SA 14-14-2 Japanese Encephalitis vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02880865 ↗
Known as SA14 14 2 vaccine “Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine), CD.JEVAX™” NCT01396512 ↗
Modality Vaccine “The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is one of three vaccines prequalified by the World Health Organization (WHO) to prevent JE.” PMID 35243320 ↗ Feb 2022
Route Subcutaneous “0.5 mL subcutaneous injection” NCT02514746 ↗